St. Jude Medical: Dealing Its Way to the Top in AF

St. Jude Medical's recent announcement that it will acquire Endocardial Solutions represents the latest step in St. Jude's aggressive strategy to become a dominant player in the atrial fibrillation (AF) market.

St. Jude Medical Inc. 's recent announcement that it will acquire Endocardial Solutions Inc. (ESI) represents the latest step in St. Jude's aggressive strategy to become a dominant player in the atrial fibrillation (AF) market. [See Deal] Buying ESI is St. Jude's third deal in this space in the past four months, preceded by its purchase of Irvine Biomedical Inc. and the completion of its acquisition of Epicor Medical Inc. [See Deal][See Deal]

Establishing itself as a leader in the AF market is an important part of St. Jude's long-term growth strategy, particularly...

In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

More from Innovation

More from In Vivo